Fractyl Health, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-25.5M | $9.2M | $-43.7M | $-45.6M | $-27.9M | $-23.7M | $-25.0M | $-23.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $278.0K | $281.0K | $279.0K | $290.0K | $270.0K | $290.0K | $223.0K | $209.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.5M | $2.5M | $1.9M | $1.6M | $1.8M | $1.4M | $2.9M | $2.5M |
| Net Cash from Operating Activities | $-15.9M | $-22.5M | $-21.3M | $-22.7M | $-21.2M | $-25.1M | $-17.0M | $-18.0M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $3.0K | $8.0K | $98.0K | $448.0K | $233.0K | $213.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-3.0K | $-8.0K | $-98.0K | $-448.0K | $-233.0K | $-213.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-127.0K | $4.1M | $25.2M | $78.1M | $1.5M | $171.0K | $67.0K | $162.0K |
| Net Change in Cash | $-16.0M | $-18.4M | $3.9M | $55.4M | $-19.8M | $-25.4M | $-17.2M | $-18.1M |
| Free Cash Flow | — | — | $-21.3M | $-22.7M | $-21.3M | $-25.5M | $-17.3M | $-18.3M |